Schedule 13G ownership disclosure
Merrimack Pharmaceuticals Inc
Security class unavailable · CUSIP: 590328209
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 813,041
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-18-002947
- Form type
- SC 13G
- Filer
- BlackRock Finance, Inc.
- CIK
- CIK 1364742
- Filed
- Jan 25, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership